Global Coronavirus (COVID-19) Current Therapy Market Report 2020-2030 | Covid 19 Impact and Recovery

Spread the love

The Business Research Company’s latest report Coronavirus (COVID-19) Current Therapy Global Market Report 2020 covers Coronavirus (COVID-19) Current Therapy market drivers, Coronavirus (COVID-19) Current Therapy market trends, Coronavirus (COVID-19) Current Therapy market segments, Coronavirus (COVID-19) Current Therapy market growth rate, Coronavirus (COVID-19) Current Therapy market major players, and Coronavirus (COVID-19) Current Therapy market size. The report provides in-depth analysis of the impact of COVID-19 on the Coronavirus (COVID-19) Current Therapy industry, along with revised market numbers due to the effects of the coronavirus.

View Complete Report:

Coronavirus (COVID-19) Current Therapy Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

Request for the sample now:

The global COVID-19 current therapy market is expected to grow from $10.83 billion in 2019 to $16.51 billion in 2020 at a compound annual growth rate (CAGR) of 52.5%. The growth is mainly attributed to the COVID-19 outbreak and the urgent need to treat the growing number of cases. With no effective therapeutics discovered so far, existing drugs such as Remdesivir, Hydroxychloroquine, Ritonavir, Lopinavir, Interferon Beta, among others are repurposed for the COVID-19 treatment. The market is then expected to stabilize and reach $27.27 billion in 2023 at a CAGR of 18.2%.

The report covers the Coronavirus (COVID-19) Current Therapy market’s segments-

1) By Drug Type: Antiviral (Remdesivir, Ritonavir, Lopinavir), Antimalarial (Hydroxychloroquine), Interferons (Interferon Beta), Corticosteroid (Dexamethasone), Others.

2) By End-Use: Hospitals, Clinics, Research Institutes, Others.

TBRC’s annual festive sale is finally here! Get up to 50% off on ALL reports:

About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 20 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected] 

Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →